The Board of Directors of Guangzhou Wondfo Biotech Co.,Ltd has authorized a buyback plan on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.94 CNY | -0.55% | -3.15% | -4.08% |
May. 06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
Apr. 21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.08% | 1.87B | |
-1.48% | 8.37B | |
+10.15% | 5.84B | |
+25.61% | 5.4B | |
-4.58% | 4.37B | |
-51.80% | 3.23B | |
+16.25% | 2.8B | |
+30.25% | 2.26B | |
-8.17% | 2.22B | |
+3.02% | 1.6B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.